-+ 0.00%
-+ 0.00%
-+ 0.00%

Rhythm Pharmaceuticals Announces Preliminary Phase 2 Data for Setmelanotide in Prader-Willi Syndrome

Reuters·12/10/2025 21:01:17

Please log in to view news